Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Tanya Clifford (NPI 1699853531)

Field	Value
Entity Type	Individual
Organization	Tanya Clifford
Address	100 E Carroll St
City	Salisbury
State	MD
ZIP	21801
Taxonomy	Nurse Practitioner
NPI Enumerated	November 1, 2006

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-centric infusion/oncology operator: lifetime Medicare revenue is $2.9M and there is no Medicaid billing on file, indicating a single‑payer footprint focused on Medicare beneficiaries rather than a mixed Medicare/Medicaid practice. The code mix is dominated by high-volume injectable oncology agents and infusion services rather than clinic-only evaluation and management revenue.

Revenue concentration is high and drug-driven: the precomputed top 3 Medicare codes account for 64.9% of the provider's total Medicare revenue, with J9271 (26K claims, $43 avg paid/claim, $1.1M revenue; 38.5% of total Medicare revenue), J9299 ($405.1K revenue; 13.9% of total Medicare revenue), and J9144 ($362.5K revenue; 12.5% of total Medicare revenue) together forming the bulk of reported Medicare receipts. This profile indicates financial dependence on a small number of high-use biologic/immunotherapy agents.

The specific codes billed point to oncology/immunotherapy specialty care: large volumes of J9271 (pembrolizumab), J9299 (nivolumab), J9144 (daratumumab) and notable billing for J9022 (atezolizumab) and chemotherapy administration codes (96413, 96401, 96417) are consistent with an infusion practice delivering checkpoint inhibitors, monoclonal antibodies, and parenteral chemotherapy. Supporting-care biologics and biosimilars such as Q5111 (pegfilgrastim-cbqv) and Q5118 (bevacizumab-bvzr) also appear, reinforcing an oncology infusion/service-line orientation rather than a primary-care model.

Competitive standing on the national Medicare stage is mixed: for the top revenue code J9271 the provider ranks #204 of 1841 (89th percentile; typical, unremarkable volume for this code), indicating solid but not dominant national activity for pembrolizumab billing. Other specialty drug ranks (for example J9299 at #208 of 505, 59th percentile; typical, unremarkable volume) show the provider is a modest participant nationally across multiple high-cost agents rather than a market leader.

Certain service and visit codes are statistical outliers in utilization relative to peers, which suggests a busy infusion clinic workflow in addition to drug administration. The E/M code 99214 is reported at 930 claims, $84 avg paid/claim, $78.1K revenue and ranks #13715 of 479517 (97th percentile; notably above typical national volume), and infusion access code 96360 ranks #80 of 2672 (97th percentile; notably above typical national volume), both flagged as notably above typical national volume and consistent with frequent, substantial face-to-face visits and infusion access procedures.

There is an operational emphasis on administration rather than laboratory or office-only services: chemotherapy administration codes such as 96413 (522 claims, $92 avg paid/claim, $48K revenue) and multiple IV/infusion add-on codes (96417, 96374, 96375, 96367) appear in the top billings, while traditional lab panels and basic office E/M codes (80053, 99213, 85025) contribute relatively small single-digit percentages of Medicare revenue. This pattern reinforces a business model built around infusions and drug reimbursement rather than ambulatory primary care or diagnostic services.

Longevity in the Medicare program is established: the provider's NPI was enumerated on 2006-11-01 (~20 years ago), indicating sustained participation in Medicare and the potential for established referral relationships and operational routines focused on infusion oncology care. The long tenure combined with concentrated drug billing suggests mature operational processes for delivering and billing high-volume injectable treatments.

While most high-volume drug codes are characterized as "typical, unremarkable volume" for national peers, there are lower-percentile drug entries (for example J9173 ranks #39 of 53, 27th percentile; typical, unremarkable volume) and low-percentile supportive-agent billing (J0185 at 22th percentile), indicating that the provider's strength is concentrated in a subset of biologics and infusions rather than across all oncology-support agents. This uneven footprint across specific drugs could reflect clinical focus, formulary choices, or referral patterns rather than broad-spectrum oncology drug provisioning.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

51 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	26,000	$40	$1.1M
J9299	Injection, nivolumab, 1 mg	16,880	$20	$405.1K
J9144	Injection, daratumumab, 10 mg and hyaluronidase‑fihj	9,540	$40	$362.5K
J9022	Injection, atezolizumab, 10 mg	5,500	$60	$351.7K
J9173	Injection, durvalumab, 10 mg	2,940	$60	$182.5K
Q5111	Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg	930	$110	$99.9K
J0897	Injection, denosumab, 1 mg	4,800	$20	$86.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	930	$80	$78.1K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	520	$90	$48K
J1437	Injection, ferric derisomaltose, 10 mg	2,690	$20	$45.7K

Showing 1–10 of 51

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 51 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Tanya Clifford — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

51 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	13	60	15,000	$40	$787.6K
J9299	16	20	24,080	$20	$660.6K
J9022	2	10	10,070	$60	$646.8K
J9144	18	30	11,970	$40	$493.5K
J9173	2	10	4,790	$60	$297.9K
J0897	140	340	3,600	$20	$114.4K
Q5118	6	10	3,970	$20	$101.8K
Q5111	6	10	930	$110	$92.7K
J0881	53	60	30,420	$1	$76.4K
J1437	26	50	2,800	$20	$75.1K

Showing 1–10 of 51

Related Providers

Other providers that share a Tax Identification Number (TIN) with Tanya Clifford, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Tidalhealth Nanticoke, Inc	DE	General Acute Care Hospital	$0	$19.2M
Tidalhealth Specialty Care, LLC	MD	Medical Specialty Clinic/Center	$0	$11.7M
Tidalhealth Physician Network, Inc.	DE	Family Medicine Physician	$0	$8.7M
Tidalhealth Peninsula Regional, Inc.	MD	General Acute Care Hospital	$0	$7.6M
Justin Kucinski	MD	Internal Medicine Physician	$6.9M	$0
Tidalhealth Physician Network, Inc.	DE	Family Medicine Physician	$0	$2.9M
Ivonne Herrera	DE	Rheumatology Physician	$2.7M	$0
Rabindra Paul	MD	Infectious Disease Physician	$2.1M	$0
Muhammad Siddique	MD	Medical Oncology Physician	$1.6M	$0
Kazi Khan	MD	Nephrology Physician	$1.6M	$0

Nearby Providers

Other providers in the same ZIP code as Tanya Clifford, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Emergency Service Associates PA	MD	Emergency Medicine Physician	$0	$24.6M
Hudson Health Services, Inc.	MD	Substance Abuse Rehabilitation Facility	$0	$23.1M
Bnj Health Services Inc Salisbury	MD	Substance Use Disorder Rehabilitation Clinic/Center	$0	$10.3M
Ydiprmc LLC	MD	Urgent Care Clinic/Center	$0	$7.3M
Cnp Operating Co LLC	MD	Multi-Specialty Clinic/Center	$0	$7.3M
Cove Recovery, LLC	MD	Addiction (Substance Use Disorder) Counselor	$0	$5.2M
Gateway Pediatrics, LLC	MD	Pediatrics Physician	$0	$5.1M
Go-getters Inc	MD	Community/Behavioral Health Agency	$0	$5M
Wicomico County Health Department	MD	Public Health or Welfare Agency	$0	$4.9M
Delmarva Radiology P.A.	MD	Diagnostic Ultrasound Physician	$0	$4.3M

Tanya Clifford — Billing Profile & Reimbursement Data

Sign up for Tanya Clifford — Billing Profile & Reimbursement Data policy alerts

Tanya Clifford — Billing Profile & Reimbursement Data

Sign up for Tanya Clifford — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References